Acessibilidade / Reportar erro

Auditory and vestibular dysfunctions in systemic sclerosis: literature review

Abstracts

Purpose:

To describe the prevalence of auditory and vestibular dysfunction in individuals with systemic sclerosis (SS) and the hypotheses to explain these changes.

Research strategy:

We performed a systematic review without meta-analysis from PubMed, LILACS, Web of Science, SciELO and SCOPUS databases, using a combination of keywords "systemic sclerosis AND balance OR vestibular" and "systemic sclerosis AND hearing OR auditory."

Selection criteria:

We included articles published in Portuguese, Spanish, or English until December 2011 and reviews, letters, and editorials were excluded. We found 254 articles, out of which 10 were selected.

Data analysis:

The study design was described, and the characteristics and frequency of the auditory and vestibular dysfunctions in these individuals were listed. Afterwards, we investigated the hypothesis built by the authors to explain the auditory and vestibular dysfunctions in SS.

Results:

Hearing loss was the most common finding, with prevalence ranging from 20 to 77%, being bilateral sensorineural the most frequent type. It is hypothesized that the hearing impairment in SS is due to vascular changes in the cochlea. The prevalence of vestibular disorders ranged from 11 to 63%, and the most frequent findings were changes in caloric testing, positional nystagmus, impaired oculocephalic response, changes in clinical tests of sensory interaction, and benign paroxysmal positional vertigo.

Conclusion:

High prevalence of auditory and vestibular dysfunctions in patients with SS was observed. Conducting further research can assist in early identification of these abnormalities, provide resources for professionals who work with these patients, and contribute to improving the quality of life of these individuals.

Systemic Scleroderma; Hearing Loss; Vestibule Labyrinth; Vertigo; Review


Objetivo:

Descrever a prevalência das alterações auditivas e vestibulares em indivíduos com Esclerose Sistêmica (ES) e as hipóteses elencadas para explicar essas alterações.

Estratégia de pesquisa:

Revisão sistemática, sem meta-análise, a partir das bases de dados PubMed, LILACS, Isi Web of Science, SciELO e SCOPUS, utilizando a combinação das palavras-chave "systemic sclerosis ANDbalance OR vestibular" e "systemic sclerosis AND hearing ORauditory".

Critérios de seleção:

Foram incluídos artigos publicados em Português, Espanhol ou Inglês até dezembro de 2011 e excluídos os artigos de revisão de literatura, cartas e editoriais. Foram localizados 254 artigos e selecionados dez.

Análise dos dados:

Foi realizada a descrição do delineamento dos estudos e elencadas as características e frequência das alterações auditivas e vestibulares. Após, investigaram-se as hipóteses formuladas pelos autores para explicar o comprometimento auditivo e vestibular na ES.

Resultados:

A perda auditiva foi o achado mais comum, com prevalência de 20 a 77%, sendo o tipo sensorioneural bilateral o mais frequente. Hipotetiza-se que o prejuízo auditivo na ES é decorrente de alterações vasculares na cóclea. A prevalência das alterações vestibulares variou de 11 a 63%, e os achados mais frequentes foram alterações na prova calórica, nistagmo de posicionamento, resposta oculocefálica anormal, alterações nos testes clínicos de integração sensorial e vertigem postural paroxística benigna.

Conclusão:

Elevada prevalência de alterações auditivas e vestibulares em pacientes com ES. A condução de novas investigações pode colaborar na identificação precoce dessas alterações, fornecer subsídios para os profissionais que atuam junto a esses pacientes e contribuir para a melhoria da qualidade de vida desses indivíduos.

Escleroderma Sistêmico; Perda Auditiva; Vestíbulo do Labirinto; Vertigem; Revisão


INTRODUCTION

Systemic sclerosis (SS), also known as systemic scleroderma, is an autoimmune connective tissue inflammatory disease, characterized by fibrosis of the skin, blood vessels, and visceral organs(11. Azevedo ABC, Sampaio-Barros PD, Torres RM, Moreira C. Avaliação da prevalência de hipertensão pulmonar na esclerose sistêmica. Rev Bras Reumatol. 2004;44(1):31-9.). It is a rare disease affecting 4–12 individuals per 1,000,000 inhabitants/year. It is more common among persons aged between 30 and 50 years, and it is at least three times more frequent among women, especially those at fertile age(22. Vilas AP, Veiga MV, Abecasis P. Esclerose sistêmica - perspectivas actuais. Med Interna. 2002;9(2):111-20.,33. Godoi ETAM, Barbosa AD, Godoi JTAM, Ramos MAM, Godoi JTAM, Marques SRB, et al. Envolvimento macrovascular e esclerose sistêmica. J Vasc Bras. 2009;8(1):65-76.). The prevalence of the disease among women suggests the involvement of sex hormones on the development of SS. Despite being known since the 18th century, and even though it has been recognized as a multisystemic pathology since the 19th century, its etiology is unknown, and its pathogenesis is not clear(22. Vilas AP, Veiga MV, Abecasis P. Esclerose sistêmica - perspectivas actuais. Med Interna. 2002;9(2):111-20.). Several chemical agents (vinyl chloride and benzene), drugs (bleomycin and toxic oil syndrome), or viral infections have been mentioned as the main precipitating factors for SS. The occurrence of the disease in other members of the family is rare(44. Borges CTL. Esclerose sistêmica. In: Yoshinari NH, Bonfá ESDO, organizadores. Reumatologia para o clínico. São Paulo: Roca; 2000. p. 49-58.).

This condition is progressive and may cause death, being clinically characterized by skin thickening and problems in visceral organs, including the gastrointestinal tract, lungs, heart, and kidneys. Fibrosis and vascular occlusion occur in all the organs affected by SS. Because of vascular occlusion, the lumen of arteries and capillaries reduces and, as a consequence, isolated pulmonary hypertension takes place, as well as the reduction of capillary network (some vessels are obstructed and others are dilated, forming the telangiectasias), arterial hypertension due to the reduced renal artery lumen, myocardial perfusion disorder, and the Raynaud's phenomenon(44. Borges CTL. Esclerose sistêmica. In: Yoshinari NH, Bonfá ESDO, organizadores. Reumatologia para o clínico. São Paulo: Roca; 2000. p. 49-58.).

Patients diagnosed with SS are classified in two subgroups, according to the extension of skin compromise(55. Santarelli R, Monte PSED, Arslan EGE. Auditory neuropathy in systemic sclerosis: a speech perception and evoked potential study before and after cochlear implantation. Eur Arch Otorhinolaryngol. 2006;263:809-15.): diffuse SS, in which skin, trunk and limbs, face, and neck are compromised; and limited SS, in which there are no trunk injuries, affecting only distal parts up to the knees and elbows, besides face and neck. The CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) is one form of limited SS(44. Borges CTL. Esclerose sistêmica. In: Yoshinari NH, Bonfá ESDO, organizadores. Reumatologia para o clínico. São Paulo: Roca; 2000. p. 49-58.).

In general, the disease has an insidious onset, and skin manifestations are followed or preceded by the Raynaud's phenomenon and edematous fingers(66. Gilliland BC. Esclerose sistêmica (esclerodermia) e distúrbios relacionados. In: Kasper DL, editor. Tratado de medicina interna. Rio de Janeiro: McGraw-Hill; 2006. p. 2076-87.,77. Skare TL. Reumatologia: princípios e práticas. Rio de Janeiro: Guanabara Koogan; 2007. p. 125-34.). Because multiple organs are affected, the disease can limit the relationships of the individuals and make social interactions more difficult, thus compromising the quality of life. A study conducted in 2012 reveals that 21–55% of the patients who have had the disease for approximately 10 years could not resume work due to their physical limitations(88. Sandqvist G, Hesselstrand R, Scheja A, Hakansson C. Managing work life with systemic sclerosis. Rheumatol. 2012;51:319-23.). Literature has also shown the presence of auditory and vestibular symptoms and changes in autoimmune diseases such as SS. However, studies that investigate these changes in SS are scarce, and the understanding of its physiopathology is still unclear. Considering that hearing enables interaction and social experiences, there is a need to investigate the integrity of this function, to intervene and minimize the losses resulting from auditory and vestibular changes, whenever possible. Besides, no publications on this subject were found in Brazil. The information about auditory and vestibular impairments in patients with SS can contribute to the knowledge of gaps about the problem, thus providing subsidies to professionals who work with these patients, improving quality of life of these patients.

OBJECTIVE

The objective of this study was to conduct a systematic literature review to describe and verify the prevalence of auditory and vestibular changes among individuals with SS, as well as to list the hypotheses formulated to explain such changes.

RESEARCH STRATEGY

For this analysis, a systematic literature review, without meta-analysis, was conducted on studies that investigated auditory and vestibular changes in patients with SS. By checking PubMed, LILACS, Web of Science, SciELO, and SCOPUS, articles published until December 2011 were obtained by a combination of the following keywords in the abstracts: "systemic sclerosis AND balance OR vestibular" and "systemic sclerosis AND hearing OR auditory." These keywords were selected after DeCS (Descritores em Ciências da Saúde) and MESH (Medical Subject Headings) were consulted. On the basis of articles that dealt with the studied topic, other free terms were also used.

SELECTION CRITERIA

The study included original research articles on auditory and vestibular changes in patients with SS published in Portuguese, Spanish, or English. All the literature reviews, letters, and editorials were excluded from the study. After reading their titles and abstracts, 15 articles were pre-selected. They all studied the matter of investigation and met the inclusion criteria defined for the study. Of the 15 articles, 5 were not available in the BIREME database; therefore, 10 articles were included in this study (Figure 1).

Figure 1
Database consultation and selection of articles

DATA ANALYSIS

For each selected article, the study design was described by using a script including location, period of publication, study design/base, and population. Afterwards, the characteristics and frequency of auditory and vestibular changes identified in individuals with SS were described. Then, the hypotheses described in the selected studies were presented to explain the physiopathology of auditory and vestibular changes in SS.

RESULTS

After consulting the electronic databases, 254 articles were found. However, only 10 were selected for this study. The most common reason for exclusion was the investigation of diagnosis, treatment, physiopathology, and other manifestations of SS that did not include auditory and vestibular changes (39%), followed by studies that reported other pathologies (28%), those in which the type of study did not meet the inclusion (16%) or language criteria (8%), and when the full text was not found (2%).

The earliest identified study was conducted in 1980, and 10 cases of patients diagnosed with SS who developed injury of the cranial nerve were reported(99. Teasdall RD, Frayaha RA, Schulman LE. Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore). 1980;59(2):149-59.) (Chart 1). From 2006 onward, more publications on studies conducted in Europe, and, in Brazil, no studies analyzing auditory and vestibular compromise in SS were identified. It can be observed that in the past four decades there were only a few studies with the objective of investigating auditory and vestibular changes among individuals with SS. It is believed that because the disease is rare and its diagnosis is late, studies to investigate auditory and balance in these individuals become compromised. Besides, we should consider that the evolution, symptoms, limitations, and prognosis of the disease draw the attention of professionals who work with these patients towards restoring the functions and skills essential to maintain their lives. However, it is noteworthy that the integrity of hearing and balance enables these patients to socialize and gain autonomy, contributing to their well-being and quality of life.

Chart 1
Characterization of the studies investigating auditory and vestibular changes in patients with systemic sclerosis

The most used study design for describing auditory and vestibular changes in individuals with SS was the cross-sectional design, observed in five analyses(1010. Berrettini S, Ferri C, Pitaro N, Bruschini P, Latorraca A, Sellari-Franceschini S, et al. Audiovestibular involvement in systemic sclerosis. ORL. 1994;56:195-8.

11. Kastanioudakis I, Ziavra N, Politi EN, Exarchakos G, Drosos AA, Skevas A. Hearing loss in progressive systemic sclerosis patients: a comparative study. Otolaryngol Head Neck Surg. 2001;124(5):522-5.

12. Amor-Dorado JC, Barreira-Fernandez MP, Arias-Nuñez MC, Gomez-Acebo A, Llorca J, Gonzalez-Gay MA. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in systemic sclerosis. Otol Neurotol. 2008;29(8):1155-61.

13. Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.
-1414. Bassyouni IH, Emad Y, Rafaat HA, Dabbous AO. Relationship between nailfold capillary abnormalities and vestibular dysfunction in systemic sclerosis. Joint Bone Spine. 2011;78(3):266-9.), followed by four case reports(66. Gilliland BC. Esclerose sistêmica (esclerodermia) e distúrbios relacionados. In: Kasper DL, editor. Tratado de medicina interna. Rio de Janeiro: McGraw-Hill; 2006. p. 2076-87.,99. Teasdall RD, Frayaha RA, Schulman LE. Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore). 1980;59(2):149-59.,1515. Abou-Taleb A, Linthicum FH Jr. Scleroderma and hearing loss: (histopathology of a case). J Laryngol Otol. 1987;101(7):656-62.,1616. Deroee AF, Huang TC, Morita N, Hojjati M. Sudden hearing loss as the presenting symptom of systemic sclerosis. Otol Neurotol. 2009;30(3):277-9.), and one case-control study(1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.). Because cross-sectional studies reported findings of a single moment, it was difficult to determine a temporal sequence between exposure to a specific factor and the subsequent development of the disease. This type of study is not considered to be the most appropriate or indicated one to investigate hearing and balance among individuals with SS. This is because there is a possibility that at the time of evaluation, auditory and vestibular changes had not manifested. Besides, it is impossible to ensure that SS was present before the development of hearing loss or vestibular changes. Therefore, and considering the progressive aspect of SS, more follow-up studies are required to establish a temporal sequence between the disease and the onset or aggravation of auditory and vestibular changes among individuals with SS.

The largest sample was observed in the study by Amor-Dorado et al.(1212. Amor-Dorado JC, Barreira-Fernandez MP, Arias-Nuñez MC, Gomez-Acebo A, Llorca J, Gonzalez-Gay MA. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in systemic sclerosis. Otol Neurotol. 2008;29(8):1155-61.), which included 42 individuals with SS, and the smallest sample was observed in the study by Maciaszczyk et al.(1313. Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.), including 20 people diagnosed with SS. The reduced number of the samples is probably because of the fact that SS is a rare and progressive disease, with several incapacitating manifestations leading to death.

Amor-Dorado et al.(1212. Amor-Dorado JC, Barreira-Fernandez MP, Arias-Nuñez MC, Gomez-Acebo A, Llorca J, Gonzalez-Gay MA. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in systemic sclerosis. Otol Neurotol. 2008;29(8):1155-61.,1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.) and Maciaszczyk et al.(1313. Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.) had differences in the study population with regard to the form of disease (limited or diffuse); however, only in the analysis by Amor-Dorado et al.(1212. Amor-Dorado JC, Barreira-Fernandez MP, Arias-Nuñez MC, Gomez-Acebo A, Llorca J, Gonzalez-Gay MA. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in systemic sclerosis. Otol Neurotol. 2008;29(8):1155-61.) results were presented by considering the type of disease. Prevalence of changes in the vestibular system was higher for patients with diffuse SS (Charts 1 and 2). Considering that the level of systemic manifestations is directly related to the form of disease presentation (limited or diffuse), it is hypothesized that auditory and vestibular changes also have these variations, which emphasizes the importance of distinguishing the study population according to the form of disease.

Chart 2
Symptoms and auditory and vestibular findings in systemic sclerosis

Only the studies by Berrettini et al.(1010. Berrettini S, Ferri C, Pitaro N, Bruschini P, Latorraca A, Sellari-Franceschini S, et al. Audiovestibular involvement in systemic sclerosis. ORL. 1994;56:195-8.) and Amor-Dorado et al.(1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.) investigated auditory and vestibular involvement in patients with SS. However, six studies aimed at assessing or reporting only auditory changes in these patients(66. Gilliland BC. Esclerose sistêmica (esclerodermia) e distúrbios relacionados. In: Kasper DL, editor. Tratado de medicina interna. Rio de Janeiro: McGraw-Hill; 2006. p. 2076-87.,99. Teasdall RD, Frayaha RA, Schulman LE. Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore). 1980;59(2):149-59.,1111. Kastanioudakis I, Ziavra N, Politi EN, Exarchakos G, Drosos AA, Skevas A. Hearing loss in progressive systemic sclerosis patients: a comparative study. Otolaryngol Head Neck Surg. 2001;124(5):522-5.,1313. Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.,1515. Abou-Taleb A, Linthicum FH Jr. Scleroderma and hearing loss: (histopathology of a case). J Laryngol Otol. 1987;101(7):656-62.,1616. Deroee AF, Huang TC, Morita N, Hojjati M. Sudden hearing loss as the presenting symptom of systemic sclerosis. Otol Neurotol. 2009;30(3):277-9.) and only two(1212. Amor-Dorado JC, Barreira-Fernandez MP, Arias-Nuñez MC, Gomez-Acebo A, Llorca J, Gonzalez-Gay MA. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in systemic sclerosis. Otol Neurotol. 2008;29(8):1155-61.,1414. Bassyouni IH, Emad Y, Rafaat HA, Dabbous AO. Relationship between nailfold capillary abnormalities and vestibular dysfunction in systemic sclerosis. Joint Bone Spine. 2011;78(3):266-9.) investigated vestibular dysfunctions (Chart 1).

It is possible to observe that symptoms of hearing loss, tinnitus, and vertigo were more frequently reported by individuals with SS. As to the presence of changes, hearing loss was the most common finding in the studies (Chart 2). However, it is important to consider that, of the 10 analyzed studies, 6 observed only hearing changes. Of the eight studies that investigated changes, all identified hearing loss in most individuals with SS, and the prevalence in this finding ranged from 20 to 77%. The type of hearing loss was bilateral sensorineural(66. Gilliland BC. Esclerose sistêmica (esclerodermia) e distúrbios relacionados. In: Kasper DL, editor. Tratado de medicina interna. Rio de Janeiro: McGraw-Hill; 2006. p. 2076-87.,99. Teasdall RD, Frayaha RA, Schulman LE. Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore). 1980;59(2):149-59.

10. Berrettini S, Ferri C, Pitaro N, Bruschini P, Latorraca A, Sellari-Franceschini S, et al. Audiovestibular involvement in systemic sclerosis. ORL. 1994;56:195-8.
-1111. Kastanioudakis I, Ziavra N, Politi EN, Exarchakos G, Drosos AA, Skevas A. Hearing loss in progressive systemic sclerosis patients: a comparative study. Otolaryngol Head Neck Surg. 2001;124(5):522-5.,1313. Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.,1616. Deroee AF, Huang TC, Morita N, Hojjati M. Sudden hearing loss as the presenting symptom of systemic sclerosis. Otol Neurotol. 2009;30(3):277-9.,1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.) in most cases, corroborating the physiopathology of the systemic disease. However, mixed(1111. Kastanioudakis I, Ziavra N, Politi EN, Exarchakos G, Drosos AA, Skevas A. Hearing loss in progressive systemic sclerosis patients: a comparative study. Otolaryngol Head Neck Surg. 2001;124(5):522-5.,1515. Abou-Taleb A, Linthicum FH Jr. Scleroderma and hearing loss: (histopathology of a case). J Laryngol Otol. 1987;101(7):656-62.,1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.) and unilateral(1313. Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.,1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.) hearing loss were also described in few cases.

The configuration and level of hearing loss were little explored in the studies. As this information is very important because it will guide the auditory rehabilitation process among these individuals, it should be included while conducting new studies. Amor-Dorado et al.(1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.) described the flat hearing loss configuration in 13 individuals and high-frequency hearing loss in 14, accounting for 27 patients with sensorineural hearing loss (SNHL). Deroee et al.(1616. Deroee AF, Huang TC, Morita N, Hojjati M. Sudden hearing loss as the presenting symptom of systemic sclerosis. Otol Neurotol. 2009;30(3):277-9.) observed high-frequency hearing loss in one of the ears and severe loss in another. In a study by Maciaszczyk et al.(1313. Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.), most individuals in the case group presented moderate hearing loss (Chart 2).

Regarding vestibular changes, prevalence ranged from 11 to 63%, and the most common findings were changes in caloric testing, positional nystagmus, abnormal oculocephalic reflex, changes in clinical tests of sensory integration, and benign paroxysmal positional vertigo(66. Gilliland BC. Esclerose sistêmica (esclerodermia) e distúrbios relacionados. In: Kasper DL, editor. Tratado de medicina interna. Rio de Janeiro: McGraw-Hill; 2006. p. 2076-87.,1010. Berrettini S, Ferri C, Pitaro N, Bruschini P, Latorraca A, Sellari-Franceschini S, et al. Audiovestibular involvement in systemic sclerosis. ORL. 1994;56:195-8.,1212. Amor-Dorado JC, Barreira-Fernandez MP, Arias-Nuñez MC, Gomez-Acebo A, Llorca J, Gonzalez-Gay MA. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in systemic sclerosis. Otol Neurotol. 2008;29(8):1155-61.,1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.). The prevalence of vestibular changes deserves the attention of professionals assist these patients, because these changes lead to balance changes, which, together with locomotive changes (characteristics of the disease), can be incapacitating and compromise the autonomy of patients with SS.

The analyzed studies have tried to elucidate the frequency and magnitude of auditory and vestibular changes by evaluating the peripheral and central systems. The basic audiological evaluation (tone audiometry, vocal audiometry, and acoustic immittance) was the most used evaluation method to identify these changes in individuals with SS(66. Gilliland BC. Esclerose sistêmica (esclerodermia) e distúrbios relacionados. In: Kasper DL, editor. Tratado de medicina interna. Rio de Janeiro: McGraw-Hill; 2006. p. 2076-87.,1010. Berrettini S, Ferri C, Pitaro N, Bruschini P, Latorraca A, Sellari-Franceschini S, et al. Audiovestibular involvement in systemic sclerosis. ORL. 1994;56:195-8.,1111. Kastanioudakis I, Ziavra N, Politi EN, Exarchakos G, Drosos AA, Skevas A. Hearing loss in progressive systemic sclerosis patients: a comparative study. Otolaryngol Head Neck Surg. 2001;124(5):522-5.,1313. Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.,1515. Abou-Taleb A, Linthicum FH Jr. Scleroderma and hearing loss: (histopathology of a case). J Laryngol Otol. 1987;101(7):656-62.,1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.). However, the brainstem auditory-evoked potentials (BAEP) and vestibular evaluation were also used for diagnostic investigation(66. Gilliland BC. Esclerose sistêmica (esclerodermia) e distúrbios relacionados. In: Kasper DL, editor. Tratado de medicina interna. Rio de Janeiro: McGraw-Hill; 2006. p. 2076-87.,1010. Berrettini S, Ferri C, Pitaro N, Bruschini P, Latorraca A, Sellari-Franceschini S, et al. Audiovestibular involvement in systemic sclerosis. ORL. 1994;56:195-8.,1313. Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.,1717. Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.). The highest prevalence of peripheral auditory changes can be the reflex of the assessment instrument used in the studies. Therefore, it is important that new studies be conducted with the objective of investigating the presence of auditory changes in the central system, as well as changes related to balance in individuals with SS.

Regarding the biological plausibility of auditory changes in individuals with SS, only one study suggested the possible mechanisms. According to Deroee et al.(1616. Deroee AF, Huang TC, Morita N, Hojjati M. Sudden hearing loss as the presenting symptom of systemic sclerosis. Otol Neurotol. 2009;30(3):277-9.), hearing damage in patients with SS first affects high-frequency hearing, and patients may not be aware of their hearing loss due to the severity of other manifestations of the disease. These authors suggest that the inflammation of small vessels in the cochlear nerve and the reduced blood flow to the cochlea may be the beginning of the inner ear pathogenesis in autoimmune diseases.

The inner ear compromise, especially the cochlea, may be a consequence of a vascular change, once this change is the base of SS physiopathology. The irregular structure of blood vessels associated with the reduced density of capillaries may result in decreased blood flow and, consequently, hypoxia(1616. Deroee AF, Huang TC, Morita N, Hojjati M. Sudden hearing loss as the presenting symptom of systemic sclerosis. Otol Neurotol. 2009;30(3):277-9.). The cochlea is a highly sensitive organ to blood changes, and the hypoxia resulting from vascular changes of the disease may lead to the death of hair cells(1818. Lazarini PR, Camargo ACK. Surdez súbita idiopática: aspectos etiológicos e fisiopatogênicos. Rev Bras Otorrinolaringol. 2006;72(4):554-61.). Clinically, these changes are expressed by SNHL, which corroborates the findings of the studies that indicate lower prevalence of this type of hearing loss.

Literature also describes mixed hearing loss in these individuals; however, no biological mechanisms that could explain this implication on SS have been reported. However, studies show the occurrence of conductive hearing loss in other autoimmune diseases such as recidivant polychondritis, thus attributing this change to the expansion of the inflammatory process to the middle ear and auditory tube(1919. Pereira DB, Amaral JLA, Szajubok JCM, Lima SMAL, Chahade AH. Manifestações otorrinolaringológicas nas doenças reumáticas auto-imunes. Rev Bras Reumatol. 2006;46(2):118-25.).

In one of the reviewed articles, the authors(1111. Kastanioudakis I, Ziavra N, Politi EN, Exarchakos G, Drosos AA, Skevas A. Hearing loss in progressive systemic sclerosis patients: a comparative study. Otolaryngol Head Neck Surg. 2001;124(5):522-5.) identified the presence of eustachian tube pathology in 3 of the 30 evaluated patients. This change may explain the presence of the conductive component in the hearing loss of patients with ES. As the physiopathology of SS involves not only vascular injuries but also tissue and joint injuries, there is also a possibility of middle ear involvement, because of the mechanical impairment of structures composing the tympanic-ossicle system, leading to changes in sound conduction.

The physiopathology of vestibular changes was not discussed in any of the articles included in this study. However, it is important to investigate how these changes occur, to intervene early, when possible, thus contributing to improvement in the quality of life of individuals who present with dysfunctions in this system, once they can empower locomotion limitations in people with SS.

Auditory and vestibular changes, when added to manifestations resulting from the disease, may lead to even significant damage when it comes to the socialization of these individuals. Therefore, knowing about these changes can indicate the need to include the evaluation of peripheral and central auditory system in the diagnosis protocol, as well as the follow-up of these people, to detect such changes and adopt rehabilitation procedures or medicines that can be applied early and be effective.

CONCLUSION

The results of the analyzed studies indicate auditory and vestibular compromise in patients with SS, and it is possible to observer higher prevalence of bilateral SNHL. The configuration and level of hearing loss were considered in a few studies, and results were inconsistent.

Auditory symptoms may precede the manifestations of the autoimmune disease; therefore, they can be useful in the early diagnosis, when SS is suspected. The early diagnosis and comprehension of the physiopathology of auditory and vestibular changes caused by SS are essential for taking necessary measures for their prevention and rehabilitation.

New investigations should be conducted with the objective of clarifying the relation between the configuration and level of hearing loss with the severity and form of disease presentation (limited or diffuse), contributing to the knowledge of whether or not the progression and form of disease affect the level of auditory and vestibular manifestations.

The analysis of the selected articles for this review indicates the importance of standardizing the measurement of study outcomes, so that it is possible to perform future meta-analyses that will contribute to practices based on evidence. Besides, the need for studies investigating the physiopathology of auditory and vestibular changes among individuals with SS is worth mentioning.

  • *
    MBR was in charge of theme conception and design, data collection, tabulation and analysis, writing the article, and approving the final version. APC contributed to the study methodology, analysis, and general orientation of the stages of manuscript elaboration, as well as approval of the final version.

REFERENCES

  • 1
    Azevedo ABC, Sampaio-Barros PD, Torres RM, Moreira C. Avaliação da prevalência de hipertensão pulmonar na esclerose sistêmica. Rev Bras Reumatol. 2004;44(1):31-9.
  • 2
    Vilas AP, Veiga MV, Abecasis P. Esclerose sistêmica - perspectivas actuais. Med Interna. 2002;9(2):111-20.
  • 3
    Godoi ETAM, Barbosa AD, Godoi JTAM, Ramos MAM, Godoi JTAM, Marques SRB, et al. Envolvimento macrovascular e esclerose sistêmica. J Vasc Bras. 2009;8(1):65-76.
  • 4
    Borges CTL. Esclerose sistêmica. In: Yoshinari NH, Bonfá ESDO, organizadores. Reumatologia para o clínico. São Paulo: Roca; 2000. p. 49-58.
  • 5
    Santarelli R, Monte PSED, Arslan EGE. Auditory neuropathy in systemic sclerosis: a speech perception and evoked potential study before and after cochlear implantation. Eur Arch Otorhinolaryngol. 2006;263:809-15.
  • 6
    Gilliland BC. Esclerose sistêmica (esclerodermia) e distúrbios relacionados. In: Kasper DL, editor. Tratado de medicina interna. Rio de Janeiro: McGraw-Hill; 2006. p. 2076-87.
  • 7
    Skare TL. Reumatologia: princípios e práticas. Rio de Janeiro: Guanabara Koogan; 2007. p. 125-34.
  • 8
    Sandqvist G, Hesselstrand R, Scheja A, Hakansson C. Managing work life with systemic sclerosis. Rheumatol. 2012;51:319-23.
  • 9
    Teasdall RD, Frayaha RA, Schulman LE. Cranial nerve involvement in systemic sclerosis (scleroderma): a report of 10 cases. Medicine (Baltimore). 1980;59(2):149-59.
  • 10
    Berrettini S, Ferri C, Pitaro N, Bruschini P, Latorraca A, Sellari-Franceschini S, et al. Audiovestibular involvement in systemic sclerosis. ORL. 1994;56:195-8.
  • 11
    Kastanioudakis I, Ziavra N, Politi EN, Exarchakos G, Drosos AA, Skevas A. Hearing loss in progressive systemic sclerosis patients: a comparative study. Otolaryngol Head Neck Surg. 2001;124(5):522-5.
  • 12
    Amor-Dorado JC, Barreira-Fernandez MP, Arias-Nuñez MC, Gomez-Acebo A, Llorca J, Gonzalez-Gay MA. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in systemic sclerosis. Otol Neurotol. 2008;29(8):1155-61.
  • 13
    Maciaszczyk K, Waszczykowska E, Pajor A, Bartkowiak-Dziankowska B, Durko T. Hearing organ disorders in patients with systemic sclerosis. Rheumatol Int. 2011;31(11):1423-8.
  • 14
    Bassyouni IH, Emad Y, Rafaat HA, Dabbous AO. Relationship between nailfold capillary abnormalities and vestibular dysfunction in systemic sclerosis. Joint Bone Spine. 2011;78(3):266-9.
  • 15
    Abou-Taleb A, Linthicum FH Jr. Scleroderma and hearing loss: (histopathology of a case). J Laryngol Otol. 1987;101(7):656-62.
  • 16
    Deroee AF, Huang TC, Morita N, Hojjati M. Sudden hearing loss as the presenting symptom of systemic sclerosis. Otol Neurotol. 2009;30(3):277-9.
  • 17
    Amor-Dorado JC, Arias-Nuñez MC, Miranda-Filloy JA, Gonzalez-Juanatey C, Llorca J, Gonzalez-Gay MA. Audiovestibular manifestations in patients with limited systemic sclerosis and centromere protein-B (CENP-B) antibodies. Medicine (Baltimore). 2008;87(3):131-41.
  • 18
    Lazarini PR, Camargo ACK. Surdez súbita idiopática: aspectos etiológicos e fisiopatogênicos. Rev Bras Otorrinolaringol. 2006;72(4):554-61.
  • 19
    Pereira DB, Amaral JLA, Szajubok JCM, Lima SMAL, Chahade AH. Manifestações otorrinolaringológicas nas doenças reumáticas auto-imunes. Rev Bras Reumatol. 2006;46(2):118-25.

Publication Dates

  • Publication in this collection
    Sep-Oct 2014

History

  • Received
    05 May 2014
  • Accepted
    07 Mar 2014
Sociedade Brasileira de Fonoaudiologia Al. Jaú, 684, 7º andar, 01420-002 São Paulo - SP Brasil, Tel./Fax 55 11 - 3873-4211 - São Paulo - SP - Brazil
E-mail: revista@codas.org.br